Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
APRE · NASDAQ · Pharmaceutical Preparations
Aprea Therapeutics (APRE) · oqro.io/stocks/APRE · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$0.229−0.2641 (−53.56%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Jan 30, 2026 · Filed Feb 2, 2026
CFO purchased ~$5.1K of APRE shares in the open marketSourceInsider trade · Traded Jan 30, 2026 · Filed Feb 2, 2026
CEO purchased ~$25K of APRE shares in the open marketSourceInsider trade · Traded Dec 10, 2025 · Filed Dec 11, 2025
CFO purchased ~$5.8K of APRE shares in the open marketSourceInsider trade · Traded Dec 10, 2025 · Filed Dec 11, 2025
Director purchased ~$25K of APRE shares in the open marketSourceInsider trade · Traded Apr 3, 2025 · Filed Apr 4, 2025
CEO purchased ~$5.6K of APRE shares in the open marketSourceInsider trade · Traded Apr 3, 2025 · Filed Apr 4, 2025
CEO purchased ~$4.5K of APRE shares in the open marketSourceInsider trade · Traded Oct 18, 2024 · Filed Oct 25, 2024
Director sold ~$30K of APRE shares in the open marketSourceInsider trade · Traded Oct 23, 2024 · Filed Oct 24, 2024
CEO purchased ~$2K of APRE shares in the open marketSourceInsider trade · Traded Oct 16, 2024 · Filed Oct 17, 2024
Director purchased ~$132K of APRE shares in the open marketSourceInsider trade · Traded Oct 15, 2024 · Filed Oct 16, 2024
CEO purchased ~$725 of APRE shares in the open marketSourceInsider trade · Traded Oct 11, 2024 · Filed Oct 16, 2024
CFO purchased ~$123 of APRE shares in the open marketSourceInsider trade · Traded Oct 14, 2024 · Filed Oct 16, 2024
Director purchased ~$490 of APRE shares in the open marketSourceInsider trade · Traded Oct 11, 2024 · Filed Oct 15, 2024
Director purchased ~$27K of APRE shares in the open marketSourceInsider trade · Traded Oct 10, 2024 · Filed Oct 15, 2024
CFO purchased ~$1.2K of APRE shares in the open marketSourceInsider trade · Traded Oct 10, 2024 · Filed Oct 15, 2024
CEO purchased ~$381 of APRE shares in the open marketSourceInsider trade · Traded Oct 14, 2024 · Filed Oct 15, 2024
CEO purchased ~$2.6K of APRE shares in the open marketSource